Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -3.00 (-0.57%)
Bid:
524.00
Ask:
526.00
Spread: 2.00 (0.382%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Contract

14 Jul 2023 07:00

RNS Number : 9567F
Galliford Try Holdings PLC
14 July 2023
 

GALLIFORD TRY APPOINTED TO £72M REMODELLING OF LANDMARK LONDON OFFICE

Galliford Try, one of the UK's leading construction groups, announces that its Building business has been appointed by St Martin's Property Investments Limited to undertake the £72m remodelling and refurbishment of Adelaide House in central London.

 

The works consist of the remodelling of the nine-storey, Grade II-listed building, adjacent to London Bridge to a Category A office standard, as well as reconfiguration and enhancement works to external areas including the roof and riverside gardens.

 

Bill Hocking, Chief Executive of Galliford Try, commented: "We are delighted to be working with St Martin's on this landmark building with a prestigious location on the banks of the Thames. Our Building team has a proud record of delivering high-quality, sustainable office spaces within the capital."

 

 

Galliford Try

 

Bill Hocking, Chief Executive 01895 855001

Andrew Duxbury, Finance Director

Kevin Corbett, General Counsel & Company Secretary

 

Notes to Editors 

Galliford Try is a trading name of Galliford Try Holdings plc, a leading UK construction group listed on the London Stock Exchange. Operating as Galliford Try and Morrison Construction, the group carries out building and infrastructure projects with clients in the public, private and regulated sectors across the UK.

For more information on the building please see https://adelaidehouse.london/. CBRE and Savills are the leasing agents.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTZZGMNGFMGFZM
Date   Source Headline
23rd Oct 202410:00 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSTransaction in Own Shares
22nd Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 202411:30 amRNSAnnual Financial Report
16th Oct 20241:00 pmRNSDirector/PDMR Shareholding
15th Oct 20247:00 amRNSTransaction in Own Shares
14th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 202410:30 amRNSDirector/PDMR Shareholding
11th Oct 20247:00 amRNSTransaction in Own Shares
10th Oct 20247:00 amRNSTransaction in Own Shares
9th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 20243:50 pmRNSDirector/PDMR Shareholding
8th Oct 20243:45 pmRNSDirector/PDMR Shareholding
8th Oct 20243:45 pmRNSDirector/PDMR Shareholding
8th Oct 20247:00 amRNSTransaction in Own Shares
4th Oct 20245:25 pmRNSDirector/PDMR Shareholding
4th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:02 amRNSLaunch of Share Buyback Programme
3rd Oct 20247:00 amRNSFinal Results
30th Sep 20243:00 pmRNSTotal Voting Rights
24th Sep 20247:00 amRNSContract
23rd Sep 20247:00 amRNSContract
20th Sep 20248:44 amRNSNotification of Full Year Results
16th Sep 20247:01 amRNS2024 Full Year Results: Revised Publication Date
2nd Sep 20242:30 pmRNSDirector Declaration
2nd Sep 202410:30 amRNSTotal Voting Rights
27th Aug 20244:14 pmRNSBlock listing Interim Review
16th Aug 20249:30 amRNSContract
31st Jul 20244:00 pmRNSTotal Voting Rights
24th Jul 202410:30 amRNSDirector Declaration
23rd Jul 20247:00 amRNSContract
11th Jul 20247:00 amRNSTrading Statement
28th Jun 202411:00 amRNSTotal Voting Rights
13th Jun 20247:00 amRNSContract
31st May 20244:00 pmRNSTotal Voting Rights
31st May 20247:00 amRNSContract
23rd May 20247:00 amRNSCapital Markets Event
30th Apr 20244:00 pmRNSTotal Voting Rights
23rd Apr 20244:00 pmRNSDirector/PDMR Shareholding
10th Apr 20245:00 pmRNSHolding(s) in Company
5th Apr 202411:00 amRNSTotal Voting Rights
28th Mar 20247:00 amRNSDirectorate Change
8th Mar 20244:00 pmRNSDirector/PDMR Shareholding
6th Mar 20247:00 amRNSHalf-year Report
4th Mar 20244:00 pmRNSTotal Voting Rights
1st Mar 20247:00 amRNSDirectorate Change
26th Feb 20246:03 pmRNSBlock listing Interim Review
22nd Feb 20247:00 amRNSContract
17th Jan 20247:00 amRNSTrading Statement
30th Nov 20234:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.